help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuse, T.
Right arrow Articles by Wada, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuse, T.
Right arrow Articles by Wada, H.
American Journal of Respiratory and Critical Care Medicine Vol 165. pp. 1511-1515, (2002)
© 2002 American Thoracic Society


Original Article

Effect of Adenosine Triphosphate–Sensitive Potassium Channel Openers on Lung Preservation

Tatsuo Fukuse, Toshiki Hirata, Mitsugu Omasa and Hiromi Wada

Department of Thoracic Surgery, Otsu Red-Cross Hospital, Otsu-City; and Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, Kyoto, Japan

Correspondence and requests for reprints should be addressed to Tatsuo Fukuse, M.D., Department of Thoracic Surgery, Otsu Red-Cross Hospital, 1-1-35 Nagara, Otsu-City 520-8511, Japan. E-mail: tafukuse{at}f4.dion.ne.jp


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
ATP-sensitive potassium channel (KATP) openers have been proven to be involved in ischemic preconditioning, which protects ischemic tissue. However, the effect of KATP openers on ischemia–reperfusion injury of the lungs remains unknown. We investigated whether a KATP opener, pinacidil, can attenuate ischemia–reperfusion injury using an ex vivo rat lung model. Heart–lung blocks were flushed and preserved with phosphate-buffered saline (control group) or with one of the solutions containing pinacidil (pinacidil group) or pinacidil + glibenclamide (a KATP blocker) (glibenclamide group). The control and glibenclamide groups showed significantly higher values with respect to shunt fraction, pulmonary arterial pressure, and peak inspiratory pressure than the pinacidil group. The concentrations of total adenine nucleotides and ATP in the lung after reperfusion became significantly lower in the control and glibenclamide groups than in the fresh group. Lipid peroxidation of the lungs increased significantly in the control and glibenclamide groups after reperfusion. State 3 mitochondrial respiration and State 3/4 ratios of mitochondrial respiration were significantly decreased in the lungs of the control and glibenclamide groups. These findings suggested that KATP openers would maintain the mitochondrial respiratory function during lung preservation, prevent lipid peroxidation after reperfusion, and attenuate ischemia–reperfusion injury.

Key Words: ATP-sensitive potassium channel openers • lung preservation • reperfusion injury • mitochondria • ATP


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In clinical lung transplantation, graft failure occurs in 10–20% of cases, and this problem remains to be solved (1). Many studies have been performed on lung reperfusion injury. The involvement of reactive oxygen species, calcium paradox, energy depletion, mitochondrial dysfunction, and cytokines has been suggested, but the precise mechanism is still unclear (2).

Recently, ATP-sensitive potassium channel (KATP) openers have been proven to be effective in the ischemic damage of the heart, and this channel has been demonstrated to be a key component of ischemic preconditioning that produces a marked protection against ischemic insult (3, 4). Several proposals have been suggested for the underlying mechanisms: reduced contraction by shortening the action potential duration to minimize the metabolic requirements of the ischemic cells and suppression of calcium ion entry into the cells by hyperpolarization of the cell membrane (5, 6). In addition, it is known that KATP openers suppress the release of superoxide from neutrophils (7). KATP openers are now considered to play central roles in the suppression of cardiac muscle reperfusion injury after it was clarified that the KATP exist not only on the cell membrane but also on the inner membrane of the mitochondria and that they play a role in the mitochondrial volume and energetics (810). On the other hand, it has been reported that opening of KATP causes an increased permeability in frog mesentery venules as measured by hydraulic conductivity (11, 12).

However, there have been only a few studies on the effect of KATP openers on lung reperfusion injury (13, 14). Moreover, there has been no study concerning the effectiveness of pinacidil (a relatively pure KATP opener) in lung preservation. For example, Khimenko and coworkers (13) clearly showed that the activation of KATP could both protect against and reverse the endothelial damage associated with reperfusion injury after warm ischemia. However, in clinical lung transplantation, the donor lung is flushed and preserved with cold solution and perfused with blood when reperfused; therefore, the experimental setting of cold ischemia, which was used in our study, would be more practical for lung preservation. Yamashita and associates (14) reported the effect of nicorandil on reperfusion injury after cold ischemia in a canine lung transplantation model. However, nicorandil is a hybrid between a nicotinamide nitrate and a KATP opener, and the nitric oxide donor effect of nicorandil cannot be ignored. Nevertheless, a recent study reported the successful ischemic preconditioning of the lungs (15), which suggests that KATP openers are effective in lung preservation.

Our previous study demonstrated the importance of vascular endothelial cell protection during lung preservation (16, 17). We also reported that the postreperfusion recovery of ATP levels was correlated with the lung reperfusion injury (18) and that mitochondrial dysfunction was likely to be involved in the lung reperfusion injury (19). To clarify the effectiveness of KATP openers in lung preservation, we examined the effect of pinacidil on pulmonary function after reperfusion. Furthermore, we studied the influence of this KATP opener on the energy metabolism during preservation and on the mitochondrial function after preservation.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Male Lewis rats (250–300 g) were used. The perfusion circuit was started using 30 ml of fresh blood that was obtained from three rats. The blood was perfused from the venous blood reservoir via pulmonary artery to the left lung using a double head roller pump. The laboratory animals were randomly divided into the following five groups. In the fresh group (n = 6), the heart–left lung blocks were reperfused immediately. In the other four groups, the heart–left lung blocks were preserved for 9 hours and then reperfused for measurement of the pulmonary function. In the control group (n = 6), 0.5 ml of phosphate-buffered saline (PBS) was administered intravenously 5 minutes before the flushing. Then, the samples were flushed with 50 ml of PBS and were inflated at an airway pressure of 14 cm H2O. In the pinacidil group (n = 6), 0.5 ml of PBS containing 0.5 mg of pinacidil was administered intravenously 5 minutes before the flushing. In the glibenclamide group (n = 6), 0.5 ml of PBS containing 0.25 mg of glibenclamide was administered intravenously 5 minutes before the flushing; then the samples were flushed with 50 ml of PBS containing 100 µM of pinacidil and 10 µM of glibenclamide. Pinacidil and glibenclamide were dissolved in dimethyl sulfoxide (DMSO) at concentrations of 1 mg/40 µl and 1 mg/100 µl, respectively. To determine the effect of DMSO on the ischemic cells, DMSO in PBS at the same concentrations as in the pinacidil group and in the glibenclamide group was administered intravenously, and then the samples were flushed likewise (the vehicle group). Blood gases in the effluent blood from the deoxygenator lung were analyzed immediately before reperfusion (baseline) and after reperfusion (at 10, 20, 30, 40, 50, 60, 90, and 120 minutes), and the wet-to-dry ratio (W/D ratio) was calculated. For the thiobarbituric acid reactants (TBARS) assay, we used the mediastinal lobe of the right lung immediately after flushing, the right middle lobe 9 hours after preservation, and one-third of the tissue of the left lung after completion of reperfusion (20). The concentration of adenine nucleotides was measured in the right mediastinal lobe immediately after flushing, in the right middle lobe after storage, and in the upper one-third of the left lung after completion of reperfusion (21, 22). Mitochondrial respiration was measured in each of the fresh, control, pinacidil, glibenclamide, and vehicle groups (n = 6, each). Mitochondria were isolated from the stored lung according to the modified Fisher's method (23). Oxygen use was measured polarographically with a Clark-type electrode. The protein concentrations were measured by the method of Lowry and colleagues (24). The terminology for mitochondrial respiratory states as defined by Chance and Williams (25) was employed. All values given in the text and figures are expressed as means ± standard error of the mean (SEM). The significance of differences among the five groups was determined using the standard analysis of variance procedures and Scheffe's multiple comparison test. A p value less than 0.05 was considered statistically significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the present study, no experiment was excluded from the data due to technical errors. A total of 180 rats was used for this study as follows: deoxygenator lung, 30; bleeder rat, 90; experimental rat for study lung, 30; and mitochondrial respiration measurement, 30. The mixed venous blood was stable after reperfusion, and its pH, partial oxygen pressure in mixed venous blood (PvO2), and mixed venous CO2 pressure (PvCO2) were within the physiologic ranges.

One of the six rats in each of the vehicle, control, and glibenclamide groups had a problem with ventilation of the experimental lungs due to exudation of fluid into the tracheal tube resulting from pulmonary edema within 60 minutes, and the measurements were stopped. However, all rats in the other two groups (i.e., the fresh and pinacidil groups) were used for measurement throughout the 120 minutes of reperfusion.

Shunt Fraction
The shunt fraction (Figure 1) in the fresh and pinacidil groups was 4–6% and was quite stable throughout the observation period. The shunt fraction in the control, vehicle, and glibenclamide groups was significantly greater than that in the pinacidil and fresh groups throughout 120 minutes of reperfusion.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Upper Panel: The shunt fraction during reperfusion in the preserved lungs of the five groups. Middle Panel: The Paw during reperfusion in the preserved lungs of the five groups. Lower Panel: The mean Ppa during reperfusion in the preserved lungs of the five groups. The five groups are represented as follows: fresh (closed squares), control (closed cirles), pinacidil (closed triangles), vehicle (closed diamonds), and glibenclamide (open squares). Bars are means ± SEM. *p < 0.05 versus the control, vehicle, and glibenclamide groups. {dagger}p < 0.01 versus the control, vehicle, and glibenclamide groups.

 
Peak Inspiratory Pressure
The peak inspiratory pressure (Figure 2) in the fresh and pinacidil groups was almost equal and stable throughout reperfusion. The PIP in the control, vehicle, and glibenclamide groups increased after reperfusion and was significantly greater than that in the pinacidil and fresh groups.



View larger version (60K):
[in this window]
[in a new window]
 
Figure 2. Wet to dry weight ratios in the preserved lungs of the five groups. Bars are means ± SEM. *p < 0.05 versus the control, vehicle, and glibenclamide groups. The five groups are represented as follows: fresh (black bar), control (dark gray bar), pinacidil (crosshatched bar), vehicle (medium gray bar), and glibenclamide (light gray bar).

 
Pulmonary Arterial Pressure
The pulmonary arterial pressure (Ppa) (Figure 1) in the fresh and pinacidil groups was stable throughout the observation period. The Ppa in the control, vehicle, and glibenclamide groups was significantly greater than that in the pinacidil and fresh groups throughout 120 minutes of reperfusion.

Wet-to-Dry Ratio
The W/D ratio (Figure 2) of the lungs in the control, vehicle, and glibenclamide groups was significantly higher than that in the fresh and pinacidil groups.

Adenine Nucleotides
After flushing and preservation, there were no significant differences in the concentrations of ATP and total adenine nucleotide (TAN) (Figure 3) among the five groups after preservation. The concentrations of ATP and TAN at the end of reperfusion in the control, vehicle, and glibenclamide groups were significantly greater than those in the fresh group. There were no differences in the plasma concentrations of TAN, ATP, adenosine diphosphate, and adenosine monophosphate during reperfusion among the groups. The hemoglobin content in the lung was 0.19 ± 0.02 mg/mg dry weight.



View larger version (53K):
[in this window]
[in a new window]
 
Figure 3. Upper Panel: TAN in the study lungs after flushing, preservation, and reperfusion. Middle Panel: ATP in the study lungs of the five groups after flushing, preservation, and reperfusion. Lower Panel: The energy charge in the study lungs of the five groups after flushing, preservation, and reperfusion. The five groups are represented as follows: fresh (black bar), control (dark gray bar), pinacidil (crosshatched bar), vehicle (medium gray bar), and glibenclamide (light gray bar). Bars are means ± SEM. *p < 0.05 versus the control, vehicle, and glibenclamide groups. {dagger}p < 0.05 versus the control group.

 
Lipid Peroxidation
There were no significant differences in the level of lipid peroxidation (Figure 4) among the groups after flushing and preservation. The level of lipid peroxidation in the control, vehicle, and glibenclamide groups increased after reperfusion and was significantly higher than that in the fresh and pinacidil groups.



View larger version (44K):
[in this window]
[in a new window]
 
Figure 4. TBARS in the lung tissue of the five groups. Bars are means ± SEM. *p < 0.05 versus the control, vehicle, and glibenclamide groups. The five groups are represented as follows: fresh (black bar), control (dark gray bar), pinacidil (crosshatched bar), vehicle (medium gray bar), and glibenclamide (light gray bar).

 
Mitochondrial Respiration
There was no significant decrease in the mitochondrial respiration (Table 1) in the pinacidil group after 9 hours of preservation. However, the State 3 respiration and the State 3/4 ratio in the control, vehicle, and glibenclamide groups were significantly lower than those in the fresh and pinacidil groups.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Mitochondrial respiration of the lungs after storage

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study, we have demonstrated that administration of KATP openers suppressed the reperfusion injury after lung preservation. Five structurally different types of potassium channel openers have been reported, i.e., cromakalim-type, pinacidil-type, minoxidil-type, aprikalim-type, and diazoxide-type (26). The common features among KATP openers include a hydrophobic group, an electron-deficient aromatic ring, and a hydrogen-binding site (27). Manley and coworkers reported that all these compounds interact with the same target protein but that the several different allosterically coupled receptor-binding sites are probably involved (26). Cromakalim and pinacidil have been the most studied KATP openers, and pinacidil, especially, has been used clinically for hypertension as an orally administered drug (28). Previously, Khimenko and coworkers (13) clearly showed that the activation of KATP (administration of cromakalim) could both protect against and reverse the endothelial damage associated with reperfusion injury after warm ischemia. Yamashita and coworkers (14) reported the effect of nicorandil, a hybrid between a nicotinamide nitrate and a KATP opener, on reperfusion injury after cold ischemia in a canine lung transplantation model. The present study is, to the best of our knowledge, the first to show the effectiveness of pinacidil, a relatively pure KATP opener, in cold storage of the lung.

We also found that pinacidil maintained the mitochondrial respiratory function during preservation and that this effect was lost by a KATP blocker, glibenclamide. We reported previously that during lung preservation, the degree of morphologic injury in the mitochondria correlated with the levels of pulmonary dysfunction such as impairment of the lung oxygenation capacity and lung compliance as well as with the level of pulmonary edema (19). We also reported that the degree of mitochondrial morphologic injury became more severe with prolongation of the preservation time and that the concentrations of ATP and TAN decreased after reperfusion (18). Therefore, maintenance of the mitochondrial respiratory function by pinacidil during ischemia may play a major role in the amelioration of reperfusion injury. The recovery of the ATP and TAN levels in the pinacidil group after reperfusion also supports our proposal. It is possible that rupture of the cellular membrane led to the loss of the TAN and ATP in the cells. However, the TAN and ATP concentrations in the blood were similar in all groups. Therefore, the latter hypothesis is not probable. The present findings are also consistent with those of Monticello and coworkers (4) who reported that KATP openers attenuated the mitochondrial swelling with disrupted cristae and electron-dense deposits after preservation. In addition, Kobara and coworkers (29) suggested that the increase in ATP concentration after reperfusion during the ischemic preconditioning was caused by protection of the mitochondrial ATPase rather than by maintenance of the stored ATP to prevent ischemia–reperfusion injury. Because the presence of mitochondrial KATP in the pulmonary artery has not yet been reported, it is unknown whether the improvement in the mitochondrial function by KATP openers in the present study was caused by maintenance of the cellular homeostasis via the sarcolemmal KATP or by the direct role of KATP on the mitochondrial inner membrane. On the other hand, He and Curry (11, 12) reported that opening of KATP caused an increased permeability in frog mesentery venules as measured by hydraulic conductivity. It has also been reported that KATP have different electrophysiologic effects depending on the kind of animals (i.e., guinea pig versus rat) (30, 31) and vessels (mesenteric artery versus cerebral artery) (32). KATP openers have an effect of vasodilation on pulmonary artery in humans (33) and rats (34). In the present study, pinacidil improved pulmonary function and attenuated pulmonary edema. Khimenko and coworkers (13) also showed that KATP openers protected lung endothelium from ischemia–reperfusion injury in rats. Because we did not measure endothelial permeability or capillary pressure, the damage reversing effect of KATP openers remains unclear. Further investigations are required to clarify this issue.

It has been reported that KATP openers suppress superoxide anions produced by neutrophils (7). The present study also demonstrated that administration of pinacidil prevented lipid peroxidation after reperfusion. As the main sources of reactive oxygen species after reperfusion, the xanthine–xanthine oxidase reaction, myeloperoxidase of the activated neutrophils, and mitochondrial respiration are likely to be involved (35). Although we did not measure myeloperoxidase activity, no significant differences in the neutrophil infiltration after reperfusion were observed in the lung tissue by light microscopy (data not shown). In addition, the possibility that pinacidil in the storage solution had an effect on the neutrophils can be ignored as pinacidil was not administered after reperfusion. Park and coworkers (36) reported that ischemic preconditioning reduced superoxide production and prevented impairment of the State 3 mitochondrial respiration induced by ischemia and reperfusion. In the present study, the mitochondrial respiratory function decreased in the control group but was maintained in the pinacidil group after preservation, thus indicating that the upregulated production of superoxides through the transition of mitochondrial permeability was likely to be responsible for the increased lipid peroxidation.

In summary, we proved that KATP openers attenuated the reperfusion injury during lung preservation, maintained the mitochondrial respiratory function after preservation, and decreased lipid peroxidation after reperfusion. Therefore, KATP openers can be a useful tool in suppressing lung reperfusion injury. It is still unknown whether this mechanism of action is mediated via the sarcolemmal or mitochondrial KATP or via an action not only on the endothelial cells but also on the neutrophils. Further investigations are required to elucidate the precise mechanism of action.


    Acknowledgments
 
This work was partially supported by a Grant-in-Aid (10671250) for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan.


    FOOTNOTES
 
This article has an online data supplement, which is accessible from this issue's table of contents online at www.atsjournals.org

Received in original form December 7, 2000; accepted in final form March 22, 2002


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant 1998;17:525–531.[Medline]
  2. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996;62:302–314.[Abstract/Free Full Text]
  3. Lawton JS, Harrington GC, Allen CT, Hsia PW, Damiano RJ Jr. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg 1996;61:1680–1688.[Abstract/Free Full Text]
  4. Monticello TM, Sargent CA, McGill JR, Barton DS, Grover GJ. Amelioration of ischemia/reperfusion injury in isolated rats hearts by the ATP-sensitive potassium channel opener BMS-180448. Cardiovasc Res 1996;31:93–101.[CrossRef][Medline]
  5. Cole WC, McPherson CD, Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571–581.[Abstract]
  6. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983; 305:147–148.[CrossRef][Medline]
  7. Pieper GM, Gross GJ. EMD 52692 (bimakalim), a new potassium channel opener, attenuates luminol-enhanced chemiluminescence and superoxide anion radical formation by zymosan-activated polymorphonuclear leukocytes. Immunopharmacology 1992;23:191–197.[CrossRef][Medline]
  8. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, Grover GJ. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: possible mechanism of cardioprotection. Circ Res 1997; 81:1072–1082.[Abstract/Free Full Text]
  9. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol 1998;275:H1567–H1576.
  10. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 1998;97:2463–2469.[Medline]
  11. He P, Curry FE. Depolarization modulates endothelial cell calcium influx and microvessel permeability. Am J Physiol 1991;261:H1246–H1254.[Abstract/Free Full Text]
  12. He P, Curry FE. Endothelial cell hyperpolarization increases[Ca2+]i and venular microvessel permeability. J Appl Physiol 1994;76:2288–2297.[Abstract/Free Full Text]
  13. Khimenko PL, Moore TM, Taylor AE. ATP-sensitive K+ channels are not involved in ischemia-reperfusion lung endothelial injury. J Appl Physiol 1995;79:554–559.[Abstract/Free Full Text]
  14. Yamashita M, Schmid RA, Fujino S, Cooper JD, Patterson GA. Nicorandil, a potent adenosine triphosphate-sensitive potassium-channel opener, ameliorates lung allograft reperfusion injury. J Thorac Cardiovasc Surg 1996;112:1307–1314.[Abstract/Free Full Text]
  15. Soncul H, Oz E, Kalaycioglu S. Role of ischemic preconditioning on ischemia-reperfusion injury of the lung. Chest 1999;115:1672–1677.[Abstract/Free Full Text]
  16. Kosaka S, Bando T, Liu C, Suzuki Y, Hitomi S, Wada H. Ultrastructural changes in canine lung preserved in newly developed solutions. J Surg Res 1996;63:467–473.[CrossRef][Medline]
  17. Fukuse T, Hirata T, Ueda M, Hitomi S, Wada H. Effects of Euro-Collins, University of Wisconsin, and new extracellular-type trehalose containing Kyoto solutions in an ex-vivo rat lung preservation model. Transplantation 1996;62:1212–1217.[CrossRef][Medline]
  18. Hirata T, Fukuse T, Nakamura T, Ueda M, Kawashima M, Hitomi S, Wada H. Reperfusion lung injury after cold preservation correlates with decreased levels of intrapulmonary high-energy phosphates. Transplantation 2000;69:1793–1801.[CrossRef][Medline]
  19. Ueda M, Kosaka S, Hirata T, Fukuse T, Suzuki Y, Hitomi S, Wada H. Mitochondrial injuries in rat lungs preserved for 17 hours: an ultrastructural study. Eur Surg Res 1999;31:162–172.[CrossRef][Medline]
  20. Ohkawa H, Onishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.[CrossRef][Medline]
  21. Cross CE, Watanabe TT, Hasegawa GK, Goralnik GN, Roertogen KE, Kaizu T, Reiser KM, Gorin AB, Last JA. Biochemical assays in lung homogenates: artifacts caused by trapped blood after reperfusion. Toxicol Appl Pharmacol 1979;48:99–109.[CrossRef][Medline]
  22. Kamiike W, Watanabe F, Hashimoto T, Tagawa K, Ikeda Y, Nakao K, Kawashima Y. Changes in cellular levels of ATP and its catabolites in ischemic rat liver. J Biochem (Tokyo) 1982;91:1349–1356.[Abstract/Free Full Text]
  23. Fisher AB, Scarpa A, LaNoue KF, Bassett D, Williamson JR. Respiration of rat lung mitochondria and the influence of Ca2+ on substrate utilization. Biochemistry 1973;12:1438–1445.[CrossRef][Medline]
  24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951;193:265–275.[Free Full Text]
  25. Chance B, Williams GR. Respiration enzymes in oxidative phosphorylation. III: the steady state. Adv Enzymol Relat Areas Mol Biol 1956;17: 409–427.
  26. Manley PW, Quast U, Andres H, Bray K. Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers. J Med Chem 1993;36:2004–2010.[CrossRef][Medline]
  27. Atwal KS. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers. J Cardiovasc Pharmacol 1994;24:S12–S17.
  28. Friedel HA, Brogden RN. Pinacidil: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs 1990;39:929–967.[Medline]
  29. Kobara M, Tatsumi T, Matoba S, Yamahara Y, Nakagawa C, Ohta B, Matsumoto T, Inoue D, Asayama J, Nakagawa M. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts. J Mol Cell Cardiol 1996;28:417–428.[CrossRef][Medline]
  30. Mehrke G, Pohl U, Daut J. Effects of vasoactive agonists on the membrane potential of cultured bovine aortic and guinea pig coronary endothelium. J Physiol Lond 1991;439:277–299.[Abstract/Free Full Text]
  31. Janigro D, West AG, Gordon EL, Winn HR. ATP-sensitive K+ channels in rat aorta and brain microvascular endothelial cells. Am J Physiol 1993;265(Cell Physiol 34):C812–C821.[Abstract/Free Full Text]
  32. McCarron TF, Quayle JM, Halpern W, Nelson MT. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries. Am J Physiol 1991;261 (Heart Circ Physiol 30):H287–H291.[Abstract/Free Full Text]
  33. Bruch L, Rubel S, Kastner A, Gellert K, Gollasch M, Witt C. Pituitary adenylate cyclase activating peptides relax human pulmonary arteries by opening of KATP and KCa channels. Thorax 1998;53:586–587.[Abstract/Free Full Text]
  34. Sheridan BC, McIntyre RC Jr, Meldrum DR, Fullerton DA. KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation. Am J Physiol 1997;273:L950–L956.[Abstract/Free Full Text]
  35. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radic Biol Med 1988;5:409–419.[CrossRef][Medline]
  36. Park JW, Chun YS, Kim YH, Kim CH, Kim MS. Ischemic preconditioning reduces Op6 generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci 1997;60:2207–2219.[CrossRef][Medline]



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Leroy, A. Dagenais, Y. Berthiaume, and E. Brochiero
Molecular identity and function in transepithelial transport of KATP channels in alveolar epithelial cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L1027 - L1037.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee
Ischemia-Reperfusion-induced Lung Injury
Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. D. McCully and S. Levitsky
The mitochondrial KATP channel and cardioprotection
Ann. Thorac. Surg., February 1, 2003; 75(2): S667 - 673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuse, T.
Right arrow Articles by Wada, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuse, T.
Right arrow Articles by Wada, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society